Evidence map›Paper›PMID 38995355›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Endometrial stromal tumor with whorling and GREB1::CTNNB1 fusion-a case report on a rare entity.

Michaela Kendall Bártů, Miroslava Flídrová, Kristýna Němejcová, Jan Hojný, Jiří Dvořák, Květoslava Michalová, Pavel Dundr

Erratum issuedAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Michaela Kendall BártůDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic. michaela.kendallbartu@vfn.cz.ORCID http://orcid.org/0000-0002-5869-3618
Miroslava FlídrováDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic.
Kristýna NěmejcováDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic.
Jan HojnýDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic.
Jiří DvořákDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic.
Květoslava MichalováDepartment of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Pavel DundrDepartment of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800, Prague, Czech Republic.

Funding

European Regional Development Fund BBMRI_CZ LM2023033European Regional Development Fund EF16_013/0001674lékařská fakulta Univerzity Karlovy UNCE/24/MED/018Ministerstvo Zdravotnictví Ceské Republiky AZV NU21-03-00122Ministerstvo Zdravotnictví Ceské Republiky DRO-VFN 64165
6 · The paper itself

Abstract

Endometrial stromal tumors are rare lesions with a diverse morphology, which may make achieving the correct diagnosis challenging in some cases. We report a case of a uterine mesenchymal tumor diagnosed as endometrial stromal nodule with a peculiar whorled morphology and GREB1::CTNNB1 fusion confirmed by transcriptome RNA sequencing. The tumor was sharply demarcated, lacked invasive growth, and had benign behavior, as the patient remained without disease recurrence 15 years later. Immunohistochemically, the tumor cells showed diffuse nuclear expression of beta-catenin, confirming the activation of the beta-catenin pathway. Our case represents only the 4th reported case of CTNNB1-rearranged endometrial stromal tumor with extensive whorling. The biological nature of uterine tumors characterized by whorled morphology and rearrangement of CTNNB1 is not yet clear, which underscores the importance of genetic profiling for accurate diagnosis and potential targeted therapies in malignant cases.

Indexed as

beta CateninBiomarkers, TumorEndometrial NeoplasmsEndometrial Stromal TumorsNeoplasm ProteinsFemaleGene FusionHumansMiddle Agedbeta CateninBiomarkers, TumorCTNNB1 protein, humanGREB1 protein, humanNeoplasm ProteinsEndometrial stromal tumorsESNGREB1GREB1::CTNNB1 fusionUterine mesenchymal tumors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.